Patents

US 12138364 B2: Decellularised cell wall structures from fungus and use thereof as scaffold materials

Granted
2024-11-12
Filed
2021-09-29 application 17488454
Type
Utility · 11 claims
Elsewhere
Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗

Abstract

Provided herein are scaffold biomaterials comprising a decellularised fungal tissue from which cellular materials and nucleic acids of the tissue are removed, the decellularised fungal tissue comprising a cellulose- or chitin-based 3-dimensional porous structure. Methods for preparing such scaffold biomaterials, as well as uses thereof as an implantable scaffold for supporting animal cell growth, for promoting tissue regeneration, for promoting angiogenesis, for a tissue replacement procedure, and/or as a structural implant for cosmetic surgery are also provided. Therapeutic treatment and/or cosmetic methods employing such scaffolds are additionally described.

Source: PVGPATDIS, file of 2026-04-10 (ipg241112.xml).

Assignees

AssigneeTypePlaceAlso on furp.orgSource
University of Ottawa 100 patentsForeign company or organizationOttawa, CAUniversity of Ottawa College or university EXACT medium confidence: identical full name, one of each nationally
UNIVERSITY OF OTTAWA Nonprofit EXACT medium confidence: identical full name, one of each nationally
PVGPATDIS, file of 2026-04-10

Inventors

InventorPlacePatentsPerson pageSource
Andrew E. PellingCarlsbad Springs, CA4PVGPATDIS, file of 2026-04-10
Charles Michel CuerrierGatineau, CA3PVGPATDIS, file of 2026-04-10
Daniel J. ModulevskyOttawa, CA3PVGPATDIS, file of 2026-04-10
Ryan HickeyOttawa, CA4PVGPATDIS, file of 2026-04-10

CPC categories

SubclassCategoryFirst groupSource
A61LMethods or apparatus for sterilising materials or objects in general; disinfection, sterilisation or deodorisation of air; chemical aspects of bandages, dressings, absorbent pads or surgical articles; materials for bandages, dressings, absorbent pads or surgical articlesA61L27/3637PVGPATDIS, file of 2026-04-10
A61PSpecific therapeutic activity of chemical compounds or medicinal preparationsA61P27/02PVGPATDIS, file of 2026-04-10
C12NMicroorganisms or enzymes; compositions thereof; propagating, preserving, or maintaining microorganisms; mutation or genetic engineering; culture mediaC12N5/0062PVGPATDIS, file of 2026-04-10

Cooperative Patent Classification, as currently assigned (one row per subclass).

Assignments and security interests

RecordedWhatFromToReel/frameSource
2021-10-26Correction
Corrective assignment to correct the first coveying party name previously recorded at reel: 057877 frame: 0151. assignor(s) hereby confirms the assignment.
PELLING, ANDREW EDWARD signed 2017-04-10
CUERRIER, CHARLES MICHEL signed 2017-04-10
MODULEVSKY, DANIEL J. signed 2017-04-10
HICKEY, RYAN JOSEPH signed 2017-05-17
UNIVERSITY OF OTTAWA OTTAWA58567/732PASDL, file of 2026-10-15
2021-10-22Assignment
Assignment of assignor's interest
PELLINH, ANDREW EDWARD signed 2017-04-10
CUERRIER, CHARLES MICHEL signed 2017-04-10
MODULEVSKY, DANIEL J. signed 2017-04-10
HICKEY, RYAN JOSEPH signed 2017-05-17
UNIVERSITY OF OTTAWA OTTAWA57877/151PASDL, file of 2026-10-15

Documents recorded with the USPTO Assignment Recordation Branch that list this patent. A security interest is a lender’s claim on the patent as collateral; a release ends it.

USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.